BONESUPPORT Q1: Initial take – Sales in line, stronger EBIT - Redeye

Redeye notes that Q1 sales were in line with our estimate, and the EBIT was 29% above our forecast. US CERAMENT G sales develop nicely, even slightly better than expected. We anticipate a positive share price reaction of c5-8% during the day.

Länk till analysen i sin helhet: https://www.redeye.se/research/998396/bonesupport-q1-initial-take-sales-in-line-stronger-ebit?utm_source=finwire&utm_medium=RSS